Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
Researchers at the National Institutes of Health (NIH) have uncovered new details about how GLP-1 weight loss drugs such as semaglutide affect brain cells, revealing internal signaling processes that scientists have only begun to understand. The findings, based on experiments in mice, shed light…